Functionally relevant mutations in alternative SMAD4 promoters were shown to be quite rare, so in the case of this tumor suppressor other mechanisms and interactions with the cellular proteotranscriptome may be more relevant [39–42]. The gene discussed is SMAD4; the disease is neoplasm.